ArticleAsian Pacific journal of cancer prevention : APJCP2026
Anti-Metastatic Effects of Crocodile Blood Powder through E-cadherin Activation and Matrix Metalloproteinase Inhibition in Hepatocellular Carcinoma Cells.
Article in Asian Pacific journal of cancer prevention : APJCP, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCrocodile blood is a rich and valuable source of bioactive compounds derived from natural products. Crocodile blood powder (CP) has garnered significant attention for its potential applications in human health treatment.
objectiveThis study aimed to investigate the effect of CP on the invasion and metastasis of hepatocellular carcinoma (HepG2) cells.
methodsWe analyzed the protein content of CP using MS/MS techniques. The effects of CP on cell proliferation, apoptosis, metastasis, and invasion were assessed using immunofluorescence, a wound healing assay, a transwell invasion assay, and Western blot analysis, respectively.
resultThe findings indicated that CP could inhibit the proliferation of HepG2 cell lines. Additionally, CP increased caspase-3 expression, inducing apoptosis in HepG2 cells. CP treatment also reduced metastasis and invasion of HepG2 cells. Immunofluorescence and Western blot analyses revealed that CP upregulated E-cadherin expression, while downregulating MMP-2 and MMP-9 expression.
conclusionOverall, this study demonstrated that CP inhibits HepG2 cell proliferation and promotes apoptosis. Furthermore, CP suppresses metastasis and invasion by increasing E-cadherin expression and downregulating MMP-2 and MMP-9. Thus, CP may serve as a promising candidate for hepatocellular carcinoma therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.